Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Hims & Hers Health, Inc.
Report date June 06, 2024 · Filed June 10, 2024
Section 16 reporting ended · disclosed 2024-06-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 74,750 |
Reported balance
After 2024-06-06 transaction · row 1
1 source rowRow 1 · 2024-06-06 · Exercise / conversion · Acquired 19,707 · Balance 74,750 F1: The RSUs vested on June 6, 2024, the date of the company's 2024 annual stockholders meeting. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-06-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-06-06 · Exercise / conversion · Disposed 19,707 · Balance 0 F2: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The RSUs vested on June 6, 2024, the date of the company's 2024 annual stockholders meeting.
F2: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2024 annual meeting of stockholders or (b) June 15, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2021 Filed Jul 30, 2021 20:49 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 56,307 | $11.50 | $647,530.50 |
DisclosureSEC source: 0000899243-21-030881 · doc4.xml · nonDerivative · entry 2 Bard Alex · CIK 0001837803 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Redpoint Ventures VI, L.P. Disclosed balance after: 10,125,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: RV VI and RA VI (as defined below) exercised warrants to purchase shares of the Issuer's Class A Common Stock. The warrants were exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, RV VI and RA VI received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrants, the withholding of shares of Class A Common Stock in the cashless exercises and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended. F3 · ownership.nature: Alex Bard is one of several members of Redpoint Ventures VI, L.L.C., the general partner of Redpoint Ventures VI, L.P. ("RV VI"), and Redpoint Associates VI, L.L.C. ("RA VI"). Mr. Bard may be deemed a beneficial owner of the securities held by RV VI and RA VI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 20:49 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 1,739 | $11.50 | $19,998.50 |
DisclosureSEC source: 0000899243-21-030881 · doc4.xml · nonDerivative · entry 1 Bard Alex · CIK 0001837803 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Redpoint Associates VI, L.L.C. Disclosed balance after: 313,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: RV VI and RA VI (as defined below) exercised warrants to purchase shares of the Issuer's Class A Common Stock. The warrants were exercised on a cashless basis pursuant to Section 6.2 of that certain Warrant Agreement, by and between the Issuer and Continental Stock Transfer & Trust, dated, July 22, 2019 (the "Warrant Agreement"), following the Issuer's Notice of Redemption dated July 9, 2021. In the cashless exercise, under the terms of the Warrant Agreement, RV VI and RA VI received 0.267 shares per warrant exercised and the Issuer withheld 0.733 shares per warrant exercised. The exercise of the warrants, the withholding of shares of Class A Common Stock in the cashless exercises and the resulting issuance of the net shares of Class A Common Stock were exempt under Rule 16b-3 of the Securities Exchange Act of 1934, as amended. F3 · ownership.nature: Alex Bard is one of several members of Redpoint Ventures VI, L.L.C., the general partner of Redpoint Ventures VI, L.P. ("RV VI"), and Redpoint Associates VI, L.L.C. ("RA VI"). Mr. Bard may be deemed a beneficial owner of the securities held by RV VI and RA VI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 17:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-014244 · doc4.xml · derivative · entry 1 Bard Alex · CIK 0001837803 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69 Underlying: Class A Common Stock · 69 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of March 15, 2021. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. F1 · derivative.exercise_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of March 15, 2021. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. F1 · derivative.expiration_date: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of March 15, 2021. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), subject to the Reporting Person's continuous service with the issuer. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:34 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 3,485 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-003110 · doc4.xml · derivative · entry 6 Bard Alex · CIK 0001837803 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,485 Underlying: Class A Common Stock · 3,485 shares Expires not disclosed F7 · derivative.exercise_price: In connection with the Merger, the Reporting Person received additional New Hims RSUs representing a portion of the aggregate 16,000,000 shares of New Hims Class A Common Stock comprising the Earn Out shares (the "Earn Out RSUs"). F8 · derivative.exercise_date: The Earn Out RSUs were received in exchange for Legacy Hims RSUs. Subject to the satisfaction of a time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition as specified in Footnote 6 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out Conditions are not met during the RSU Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited. F8 · derivative.expiration_date: The Earn Out RSUs were received in exchange for Legacy Hims RSUs. Subject to the satisfaction of a time-based vesting and share-price based performance based vesting conditions, each Earn Out RSU represents the right to receive one share of Class A Common Stock of New Hims. The recipient will be subject to substantially the same time-based vesting condition as specified in Footnote 6 above. Additionally, the Earn Out RSUs will vest upon the satisfaction of the Earn Out conditions. If the RSU Earn Out Conditions are not met during the RSU Earn Out Period, then the applicable Earn Out RSUs will be automatically forfeited. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:34 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantRestricted Stock Unit · Derivative | 35,627 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-003110 · doc4.xml · derivative · entry 5 Bard Alex · CIK 0001837803 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,627 Underlying: Class A Common Stock · 35,627 shares Expires not disclosed F5 · derivative.exercise_price: In connection with the Merger, the Reporting Person received New Hims restricted stock units ("New Hims RSUs") in exchange for restricted stock units of Hims, Inc. ("Legacy Hims RSUs"). F6 · derivative.exercise_date: The New Hims RSUs were received in exchange for 78,651 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period commencing in March 2021, with 25% vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the New Hims RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with Him News. The New Hims RSU expires in January 2028. F6 · derivative.expiration_date: The New Hims RSUs were received in exchange for 78,651 Legacy Hims RSUs. The New Hims RSUs vest over a 4-year period commencing in March 2021, with 25% vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or following the one-year anniversary of the vesting commencement date and the remaining 75% of the New Hims RSUs vesting in equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter, subject to the individual's continuous service with Him News. The New Hims RSU expires in January 2028. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:34 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantWarrant (right to buy) · Derivative | 56,307 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000899243-21-003110 · doc4.xml · derivative · entry 4 Bard Alex · CIK 0001837803 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Redpoint Ventures VI, L.P. Disclosed balance after: 56,307 Underlying: Class A Common Stock · 56,307 shares Expires 2026-01-20 F4 · derivative.exercise_date: In connection with the Merger, the Reporting Person received warrants exercisable for shares of New Hims Class A Common Stock in exchange for Class A Common Stock of Hims, Inc. F9 · ownership.nature: Alex Bard is one of several members of Redpoint Ventures VI, L.L.C., the general partner of Redpoint Ventures VI, L.P. ("RV VI"), and Redpoint Associates VI, L.L.C. ("RA VI"). Mr. Bard may be deemed a beneficial owner of the securities held by RV VI and RA VI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:34 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantWarrant (right to buy) · Derivative | 1,739 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000899243-21-003110 · doc4.xml · derivative · entry 3 Bard Alex · CIK 0001837803 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Redpoint Associates VI, L.L.C. Disclosed balance after: 1,739 Underlying: Class A Common Stock · 1,739 shares Expires 2026-01-20 F4 · derivative.exercise_date: In connection with the Merger, the Reporting Person received warrants exercisable for shares of New Hims Class A Common Stock in exchange for Class A Common Stock of Hims, Inc. F9 · ownership.nature: Alex Bard is one of several members of Redpoint Ventures VI, L.L.C., the general partner of Redpoint Ventures VI, L.P. ("RV VI"), and Redpoint Associates VI, L.L.C. ("RA VI"). Mr. Bard may be deemed a beneficial owner of the securities held by RV VI and RA VI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:34 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantClass A Common Stock | 10,069,213 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-003110 · doc4.xml · nonDerivative · entry 2 Bard Alex · CIK 0001837803 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Redpoint Ventures VI, L.P. Disclosed balance after: 10,069,213 F3 · price: In connection with the Merger, the Reporting Person received (i) 9,172,003 shares of Class A Common Stock of New Hims and (ii) 897,210 Earn Out Shares in exchange for 20,248,131 shares of Class A Common Stock of Hims, Inc. If the Earn Out Conditions are not met during the Earn Out Period, then the applicable Earn Out Shares shall be automatically forfeited. On the effective date of the Merger, the closing price of New Hims Class A Common Stock was $16.38 per share. F9 · ownership.nature: Alex Bard is one of several members of Redpoint Ventures VI, L.L.C., the general partner of Redpoint Ventures VI, L.P. ("RV VI"), and Redpoint Associates VI, L.L.C. ("RA VI"). Mr. Bard may be deemed a beneficial owner of the securities held by RV VI and RA VI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 21:34 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | GrantClass A Common Stock | 311,414 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-003110 · doc4.xml · nonDerivative · entry 1 Bard Alex · CIK 0001837803 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Redpoint Associates VI, L.L.C. Disclosed balance after: 311,414 F1 · price: In connection with the merger described in that certain Agreement and Plan of Merger, dated as of September 30, 2020 (the "Merger"), by and among Oaktree Acquisition Corp., now known as Hims & Hers Health, Inc. ("New Hims"), RX Merger Sub Inc., and Hims, Inc., the Reporting Person received (i) 283,667 shares of Class A Common Stock of New Hims and (ii) 27,747 shares of restricted New Hims Class A Common Stock (the "Earn Out Shares") in exchange for 626,229 shares of Class A Common Stock of Hims, Inc. The Earn Out Shares vest in equal thirds if the trading price of New Hims Class A Common Stock is greater than or equal to $15, $17.50 and $20 for any 10 trading days within any 20-trading day period (the "Earn Out Conditions"). If the Earn Out Conditions are not met during the five years following closing (the "Earn Out Period"), then the unvested Earn Out Shares will be automatically forfeited. F2 · price: (Continued from footnote 1) On the effective date of the Merger, the closing price of New Hims Class A Common Stock was $16.38 per share. F9 · ownership.nature: Alex Bard is one of several members of Redpoint Ventures VI, L.L.C., the general partner of Redpoint Ventures VI, L.P. ("RV VI"), and Redpoint Associates VI, L.L.C. ("RA VI"). Mr. Bard may be deemed a beneficial owner of the securities held by RV VI and RA VI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.